Deep Health AI India Limited (formerly Deep Diamond India Limited) has submitted comprehensive voting results along with the scrutinizer's report for its postal ballot conducted under Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company announced this development through its disclosure to BSE Limited on March 28, 2026.

Official Disclosure and Regulatory Compliance

The company has made an official disclosure pursuant to Regulation 30 read with Part A of Schedule III of Listing Regulations, confirming that shareholders have approved the proposed resolution through postal ballot conducted via remote e-voting. The disclosure was signed by Managing Director Narayan Singh Rathore (DIN: 10900646) and submitted to BSE Limited with scrip code 539559.

Postal Ballot Results and Voting Details

The shareholders overwhelmingly approved the proposed resolution to increase the authorized share capital through the postal ballot mechanism conducted entirely via remote e-voting. The voting process was scrutinized by M/s Ronak Jhuthawat & Co., Practicing Company Secretaries (Certificate of Practice No. 12094).

Voting Outcome Analysis

The resolution received strong shareholder support with detailed voting statistics revealing the extent of approval for the capital structure enhancement.

Resolution Details and Corporate Action

The shareholders considered and approved the ordinary resolution to increase the authorized share capital of the company along with consequential alteration in the capital clause of the memorandum of association. This represents a significant step in the company's capital structure enhancement, with the resolution passing with the requisite majority.

Company Information and Documentation

Deep Health AI India Limited operates from its registered office at 309, 3rd Floor, V Star Plaza, Plot No. 16, Chandavarkar Road, Borivali West, Mumbai, Maharashtra 400092, with its corporate office located at 506-509 fifth floor, Apeksha, plot no. 256, Main Road, Hiran Magri, Sector 11, Udaipur, Rajasthan. The voting results and scrutinizer's report are available on the company's website at deephealthaiindia.com for stakeholder access, ensuring transparency in corporate governance.

Deep diamond AI India Limited has announced the appointment of Mrs. Shashi Kala Dhabriya as Additional Non-Executive Independent Director, effective March 20, 2026. The appointment was formalized through a Board Circular Resolution and disclosed to BSE Limited in compliance with regulatory requirements.

Appointment Details

The Board of Directors approved Mrs. Dhabriya's appointment through a Circular Resolution on March 20, 2026. The appointment has been made in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Director Profile and Qualifications

Mrs. Shashi Kala Dhabriya brings academic credentials to the board, holding a Master of Arts (M.A.) in History from the University of Rajasthan, which she completed in 1981. The company has confirmed that she is not inter-se related to any other directors currently serving on the board.

Regulatory Compliance

The appointment disclosure was submitted to BSE Limited under the company's scrip code 539559. The notification was made pursuant to Regulation 30 read with Para A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated January 30, 2026.

Company Background

Deep Health AI India Limited, formerly known as Deep Diamond India Limited, operates with its registered office in Mumbai, Maharashtra, and corporate office in Udaipur, Rajasthan. The company's CIN is L24100MH1994PLC082609, and it was incorporated in 1994. The appointment notification was signed by Managing Director Narayan Singh Rathore (DIN: 10900646).